Karen J Wernli1, Katherine A Callaway2, Louise M Henderson3, Karla Kerlikowske4,5,6, Janie M Lee7, Dennis Ross-Degnan2, Jamie K Wallace2, J Frank Wharam2, Fang Zhang2, Natasha K Stout2. 1. Kaiser Permanente Washington Health Research Institute, Seattle, Washington. 2. Department of Population Medicine, Harvard Medical School, Harvard Pilgrim Health Care Institute, Boston, Massachusetts. 3. Department of Radiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. 4. Department of Medicine, University of California at San Francisco, San Francisco, California. 5. Department of Epidemiology and Biostatistics, University of California at San Francisco, San Francisco, California. 6. General Internal Medicine Section, Department of Veterans Affairs, University of California at San Francisco, San Francisco, California. 7. Department of Radiology, University of Washington, Seattle, Washington.
Abstract
BACKGROUND: Supplemental breast cancer screening with breast magnetic resonance imaging (MRI) is recommended for women at high risk of breast cancer. To the authors' knowledge, recent national trends in breast MRI use are unknown. METHODS: The authors used claims data from a large national insurer to calculate screening breast MRI rates from 2006 to 2016 in a US cohort of 10 million women aged 20 to 64 years. Use was stratified by subgroups of women with a BRCA mutation, family history of breast cancer, and prior breast cancer history and stratified by age. Joinpoint regression evaluated annual changes in trends. RESULTS: The total sample included 37,447 screening breast MRI examinations in 25,617 women. Overall screening breast MRI rates were low and increased from 2.9 to 12.1 examinations per 10,000 women from 2006 to 2016. MRI use in women with a BRCA mutation increased by 21% on average annually from 210.8 per 10,000 women to 1562.0 per 10,000 women from 2006 to 2016. By 2016, women aged 50 to 64 years who had a BRCA mutation had the highest use of breast MRI (1669.6 MRI examinations per 10,000 women) compared with younger women (1198.4 MRI examinations per 10,000 women, 1519.1 MRI examinations per 10,000 women, and 1567.2 MRI examinations per 10,000 women, respectively, among women aged 20-29 years, 30-39 years, and 40-49 years). Women with a BRCA mutation comprised <1% of the current study population but received approximately 9% of screening breast MRI examinations. Breast MRI rates among women with a family history of breast cancer or prior breast cancer history initially increased from 2006 to 2008, but then stabilized or decreased. CONCLUSIONS: The increases in breast MRI use observed in the current study have indicated improvements in concordance with breast imaging guidelines. However, women with BRCA mutations remain underscreened, particularly younger women, thereby identifying a clear gap with which to enhance access.
BACKGROUND: Supplemental breast cancer screening with breast magnetic resonance imaging (MRI) is recommended for women at high risk of breast cancer. To the authors' knowledge, recent national trends in breast MRI use are unknown. METHODS: The authors used claims data from a large national insurer to calculate screening breast MRI rates from 2006 to 2016 in a US cohort of 10 million women aged 20 to 64 years. Use was stratified by subgroups of women with a BRCA mutation, family history of breast cancer, and prior breast cancer history and stratified by age. Joinpoint regression evaluated annual changes in trends. RESULTS: The total sample included 37,447 screening breast MRI examinations in 25,617 women. Overall screening breast MRI rates were low and increased from 2.9 to 12.1 examinations per 10,000 women from 2006 to 2016. MRI use in women with a BRCA mutation increased by 21% on average annually from 210.8 per 10,000 women to 1562.0 per 10,000 women from 2006 to 2016. By 2016, women aged 50 to 64 years who had a BRCA mutation had the highest use of breast MRI (1669.6 MRI examinations per 10,000 women) compared with younger women (1198.4 MRI examinations per 10,000 women, 1519.1 MRI examinations per 10,000 women, and 1567.2 MRI examinations per 10,000 women, respectively, among women aged 20-29 years, 30-39 years, and 40-49 years). Women with a BRCA mutation comprised <1% of the current study population but received approximately 9% of screening breast MRI examinations. Breast MRI rates among women with a family history of breast cancer or prior breast cancer history initially increased from 2006 to 2008, but then stabilized or decreased. CONCLUSIONS: The increases in breast MRI use observed in the current study have indicated improvements in concordance with breast imaging guidelines. However, women with BRCA mutations remain underscreened, particularly younger women, thereby identifying a clear gap with which to enhance access.
Authors: Debbie Saslow; Carla Boetes; Wylie Burke; Steven Harms; Martin O Leach; Constance D Lehman; Elizabeth Morris; Etta Pisano; Mitchell Schnall; Stephen Sener; Robert A Smith; Ellen Warner; Martin Yaffe; Kimberly S Andrews; Christy A Russell Journal: CA Cancer J Clin Date: 2007 Mar-Apr Impact factor: 508.702
Authors: Christine Leopold; Anita K Wagner; Fang Zhang; Christine Y Lu; Craig C Earle; Larissa Nekhlyudov; Dennis Ross-Degnan; J Frank Wharam Journal: Breast Cancer Res Treat Date: 2018-06-01 Impact factor: 4.872
Authors: Diana S M Buist; Linn Abraham; Christoph I Lee; Janie M Lee; Constance Lehman; Ellen S O'Meara; Natasha K Stout; Louise M Henderson; Deirdre Hill; Karen J Wernli; Jennifer S Haas; Anna N A Tosteson; Karla Kerlikowske; Tracy Onega Journal: JAMA Intern Med Date: 2018-04-01 Impact factor: 21.873
Authors: Dorothy A Sippo; Kristine S Burk; Sarah F Mercaldo; Geoffrey M Rutledge; Christine Edmonds; Zoe Guan; Kevin S Hughes; Constance D Lehman Journal: Radiology Date: 2019-05-07 Impact factor: 11.105
Authors: Deirdre A Hill; Jennifer S Haas; Robert Wellman; Rebecca A Hubbard; Christoph I Lee; Jennifer Alford-Teaster; Karen J Wernli; Louise M Henderson; Natasha K Stout; Anna N A Tosteson; Karla Kerlikowske; Tracy Onega Journal: J Gen Intern Med Date: 2017-12-06 Impact factor: 5.128
Authors: Debra L Monticciolo; Mary S Newell; Linda Moy; Bethany Niell; Barbara Monsees; Edward A Sickles Journal: J Am Coll Radiol Date: 2018-01-19 Impact factor: 5.532
Authors: Natasha K Stout; Larissa Nekhlyudov; Lingling Li; Elisabeth S Malin; Dennis Ross-Degnan; Diana S M Buist; Marjorie A Rosenberg; Marina Alfisher; Suzanne W Fletcher Journal: JAMA Intern Med Date: 2014-01 Impact factor: 21.873
Authors: Karen J Wernli; Laura Ichikawa; Karla Kerlikowske; Diana S M Buist; Susan D Brandzel; Mary Bush; Dianne Johnson; Louise M Henderson; Larissa Nekhlyudov; Tracy Onega; Brian L Sprague; Janie M Lee; Constance D Lehman; Diana L Miglioretti Journal: Radiology Date: 2019-06-04 Impact factor: 29.146
Authors: Michelle V Lee; Shani Aharon; Kevin Kim; Katerina Sunn Konstantinoff; Catherine M Appleton; Dustin Stwalley; Margaret A Olsen Journal: J Breast Imaging Date: 2021-12-11